Histological measurement of tumour angiogenesis

European Journal of Cancer

Volumn 39, Issue 7, 2003, Pages 859-860

  Boyle, J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ANTINEOPLASTIC AGENT; ENDOSTATIN; PROTEIN TYROSINE KINASE INHIBITOR;

ANGIOGENESIS; AUTOANALYSIS; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SIZE; CARCINOGENESIS; CLINICAL TRIAL; COLORECTAL CARCINOMA; DIFFUSION COEFFICIENT; EDITORIAL; ENDOMETRIUM CARCINOMA; HISTOLOGY; HODGKIN DISEASE; HUMAN; LIVER CELL CARCINOMA; LUNG SMALL CELL CANCER; MEASUREMENT; MELANOMA; MESOTHELIOMA; MICROVASCULATURE; MORPHOMETRICS; NONHUMAN; NUTRIENT SUPPLY; OXYGEN SUPPLY; PANCREAS ADENOCARCINOMA; PANCREAS ISLET CELL HYPERPLASIA; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS; STAINING; TUMOR VASCULARIZATION;

EID: 0037403275     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00121-7     Document Type: Editorial

References (14)

1. Offersen BV, Borre M, Overgaard J. Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer, 39, this issue (doi:10.1016/50959-8049(03)00121-7).
2. Hlatky L., Hahnfeldt P., Folkman J. Clinical application of antiangiogenic therapy. microvessel density, what it does and doesn't tell us J. Natl. Cancer Inst. 94:2002;883-893.
3. Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 339:1989;58-61.
4. Kerbel R., Folkman J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer. 2:2002;727-739.
5. Maxwell P.H., Ratcliffe P.J. Oxygen sensors and angiogenesis. Semin. Cell Dev. Biol. 13:2002;29-37.
6. Tanaka F., Otake Y., Yanagihara K.et al. Evaluation of angiogenesis in non-small cell lung cancer. comparison between anti-CD34 antibody and anti-CD105 antibody Clin. Cancer Res. 7:2001;3410-3415.
7. Vermeulen P.B., Gasparini G., Fox S.B.et al. Quantification of angiogenesis in solid human tumours. an international consensus on the methodology and criteria of evaluation Eur. J. Cancer. 32A:1996;2474-2484.
8. Boyle J.J., Wilson B., Bicknell R., Harrower S., Weissberg P.L., Fan T.P. Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis. J. Pathol. 192:2000;234-242.
9. Massi D., Franchi A., Borgognoni L., Paglierani M., Reali U.M., Santucci M. Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma. A quantitative morphologic analysis. Virchows Arch. 440:2002;22-28.
10. Baak J.P. The framework of pathology. good laboratory practice by quantitative and molecular methods J. Pathol. 198:2002;277-283.
11. Brem S., Cotran R., Folkman J. Tumor angiogenesis. a quantitative method for histologic grading J. Natl. Cancer Inst. 48:1972;347-356.
12. Augustin H. Tumour Angiogenesis. 2002;Vascular Biology Symposium, London.
13. Vermeulen P.B., Gasparini G., Fox S.B., Colpaert C., Marson L.P., Gion M.et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J. Cancer. 38(12):2002;1564-1579.
14. Thompson W.D. Tumour versus patient: vascular and tumour survival versus prognosis. J Pathol. 193(4):2001;425-426.